关注
RAKESH KUMAR DHRITLAHRE
RAKESH KUMAR DHRITLAHRE
PhD Scholar
在 acsir.res.in 的电子邮件经过验证
标题
引用次数
引用次数
年份
Recent advances in HER2-targeted delivery for cancer therapy
RK Dhritlahre, A Saneja
Drug discovery today 26 (5), 1319-1329, 2021
372021
Self-emulsifying formulations to augment therapeutic efficacy of nutraceuticals: From concepts to clinic
RK Dhritlahre, Y Padwad, A Saneja
Trends in Food Science & Technology 115, 347-365, 2021
142021
Recent advances in dual-ligand targeted nanocarriers for cancer therapy
N Khan, RK Dhritlahre, A Saneja
Drug Discovery Today 27 (8), 2288-2299, 2022
112022
Formononetin-Vitamin E Conjugate Synergistically Supports Adipogenesis, Attenuates Oxidative Stress, and Restores Insulin Sensitization in Differentiated Preadipocytes
AS R. K. Dhritlahre, A. Goel, R. Rana, S. K. Maurya, Y. Padwad
ChemistrySelect, ISSN:2365-6549 9 (1), e202304640, 2024
2024
Amorphous solid dispersion augments the bioavailability of phloretin and its therapeutic efficacy via targeting mTOR/SREBP-1c axis in NAFLD mice
J Chhimwal, RK Dhritlahre, P Anand, V Patial, A Saneja, YS Padwad
Biomaterials Advances 154, 213627, 2023
2023
Nano-delivery of Bioactive Constituents from Apple Pomace
Ruchika, RK Dhritlahre, A Saneja
Sustainable Agriculture Reviews 56: Bioconversion of Food and Agricultural …, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–6